X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2273) 2273
Newsletter (172) 172
Publication (112) 112
Newspaper Article (39) 39
Book Review (28) 28
Book Chapter (16) 16
Magazine Article (10) 10
Conference Proceeding (9) 9
Dissertation (3) 3
Data Set (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1657) 1657
cladribine (1452) 1452
male (817) 817
cladribine - therapeutic use (764) 764
female (687) 687
hematology (687) 687
middle aged (646) 646
oncology (596) 596
index medicus (547) 547
adult (542) 542
aged (522) 522
2-chlorodeoxyadenosine (488) 488
antineoplastic agents - therapeutic use (432) 432
cladribine - administration & dosage (363) 363
multiple sclerosis (358) 358
leukemia, hairy cell - drug therapy (351) 351
treatment outcome (325) 325
cladribine - adverse effects (288) 288
fludarabine (277) 277
cladribine - pharmacology (274) 274
therapy (257) 257
chronic lymphocytic-leukemia (232) 232
rituximab (229) 229
leukemia (224) 224
remission induction (224) 224
leukemia, lymphocytic, chronic, b-cell - drug therapy (222) 222
vidarabine - analogs & derivatives (220) 220
antineoplastic combined chemotherapy protocols - therapeutic use (211) 211
cancer (210) 210
hairy cell leukemia (206) 206
immunosuppressive agents - therapeutic use (197) 197
pentostatin (181) 181
aged, 80 and over (174) 174
pharmacology & pharmacy (172) 172
care and treatment (171) 171
animals (166) 166
drug therapy (161) 161
antineoplastic agents - pharmacology (160) 160
research (156) 156
chemotherapy (153) 153
toxicity (149) 149
recurrence (143) 143
term-follow-up (138) 138
antineoplastic agents - adverse effects (136) 136
hairy-cell leukemia (133) 133
apoptosis (132) 132
2-chloro-2'-deoxyadenosine (130) 130
antineoplastic agents - administration & dosage (130) 130
leukemia, hairy cell - pathology (122) 122
clinical neurology (117) 117
pentostatin - therapeutic use (117) 117
diagnosis (115) 115
medicine, general & internal (113) 113
follow-up studies (107) 107
medicine & public health (105) 105
prognosis (105) 105
chronic lymphocytic leukemia (104) 104
multiple sclerosis - drug therapy (103) 103
vidarabine - therapeutic use (102) 102
interferon (100) 100
nucleoside analogs (100) 100
2-cda (99) 99
retrospective studies (99) 99
cyclophosphamide (96) 96
apoptosis - drug effects (95) 95
dose-response relationship, drug (93) 93
pharmaceutical industry (93) 93
minimal residual disease (90) 90
clinical trials (89) 89
leukemia, hairy cell (89) 89
biochemistry & molecular biology (87) 87
non-hodgkins-lymphoma (87) 87
clinical trials as topic (86) 86
disease-free survival (86) 86
drugs (86) 86
splenectomy (85) 85
survival analysis (85) 85
disease progression (83) 83
lymphoma (82) 82
drug administration schedule (81) 81
analysis (80) 80
acute myeloid-leukemia (77) 77
antibodies, monoclonal - therapeutic use (77) 77
cytarabine (77) 77
deoxycytidine kinase (77) 77
tumor cells, cultured (77) 77
leukemia, lymphocytic, chronic, b-cell - pathology (76) 76
vidarabine - pharmacology (76) 76
leukemia, hairy cell - diagnosis (75) 75
survival rate (75) 75
time factors (75) 75
dosage and administration (74) 74
interferon-alpha - therapeutic use (74) 74
adolescent (73) 73
antibodies, monoclonal, murine-derived (73) 73
transplantation (73) 73
infusions, intravenous (72) 72
remission (72) 72
double-blind (71) 71
drug resistance, neoplasm (71) 71
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2313) 2313
German (40) 40
French (36) 36
Polish (22) 22
Czech (18) 18
Japanese (17) 17
Spanish (17) 17
Chinese (11) 11
Russian (8) 8
Danish (3) 3
Hungarian (3) 3
Bosnian (2) 2
Norwegian (2) 2
Persian (2) 2
Slovak (2) 2
Swedish (2) 2
Turkish (2) 2
Croatian (1) 1
Dutch (1) 1
Finnish (1) 1
Hebrew (1) 1
Portuguese (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the Neurological Sciences, ISSN 0022-510X, 2015, Volume 357, pp. e313 - e313
Journal Article
Nature Reviews Neurology, ISSN 1759-4758, 10/2017, Volume 13, Issue 10, pp. 573 - 574
Journal Article
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 07/2015, Volume 23, Issue 13, pp. 3287 - 3296
Journal Article
Blood, ISSN 0006-4971, 2015, Volume 126, Issue 12, pp. 1415 - 1423
Journal Article
MULTIPLE SCLEROSIS JOURNAL, ISSN 1352-4585, 10/2018, Volume 24, Issue 12, pp. 1617 - 1626
Objective: This propensity score-matched analysis from MSBase compared the effectiveness of cladribine with interferon , fingolimod or natalizumab. Methods: We... 
ORAL CLADRIBINE | fingolimod | disability | Cladribine | relapses | OUTCOMES | interferon | NEUROSCIENCES | natalizumab | CLINICAL NEUROLOGY
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 03/2018, Volume 19, Issue 5, pp. 483 - 498
Introduction: Multiple sclerosis (MS) is an immune-mediated and neurodegenerative disease with an unpredictable outcome. Immune-modulatory treatment aims at... 
interferon beta | Multiple sclerosis | ocrelizumab | dimethylfumarate | alemtuzumab | cladribine | fingolimod | teriflunomide | glatiramer acetate | natalizumab | daclizumab | HIGH-YIELD PROCESS | CONTROLLED PHASE-3 | GRANULE CELL NEURONOPATHY | FUMARIC-ACID ESTERS | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | VARICELLA-ZOSTER-VIRUS | INTERFERON-BETA THERAPY | TERM-FOLLOW-UP | PHARMACOLOGY & PHARMACY | PLACEBO-CONTROLLED TRIAL | DISEASE-MODIFYING THERAPIES | Alemtuzumab - adverse effects | Neoplasms - etiology | Crotonates - metabolism | Alemtuzumab - metabolism | Humans | Immunosuppressive Agents - therapeutic use | Natalizumab - adverse effects | Natalizumab - metabolism | Interferon-beta - therapeutic use | Interferon-beta - adverse effects | Natalizumab - therapeutic use | Fingolimod Hydrochloride - adverse effects | Fingolimod Hydrochloride - therapeutic use | Toluidines - therapeutic use | Toluidines - metabolism | Toluidines - adverse effects | Fingolimod Hydrochloride - metabolism | Crotonates - therapeutic use | Glatiramer Acetate - adverse effects | Cladribine - metabolism | Interferon-beta - metabolism | Cladribine - therapeutic use | Glatiramer Acetate - therapeutic use | Multiple Sclerosis - pathology | Glatiramer Acetate - metabolism | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Cladribine - adverse effects | Crotonates - adverse effects | Alemtuzumab - therapeutic use | Immunologic Factors - therapeutic use | Multiple Sclerosis - drug therapy
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 10/2018, Volume 24, Issue 11, pp. 1461 - 1468
Journal Article
Journal of Chromatography B, ISSN 1570-0232, 05/2017, Volume 1053, pp. 101 - 110
Purine nucleoside analogues are widely used in the treatment of haematological malignancies, and their biological activity is dependent on the intracellular... 
Clofarabine | Fludarabine | Nucleoside 5′-triphosphate | LC–MS/MS | 2′-Deoxyadenosine 5′ -triphosphate | Cladribine | CHEMISTRY, ANALYTICAL | Nucleoside 5 '-triphosphate | NUCLEOSIDE ANALOGS | BIOCHEMICAL RESEARCH METHODS | HYDROPHILIC INTERACTION CHROMATOGRAPHY | TANDEM MASS-SPECTROMETRY | 2 '-Deoxyadenosine 5 '-triphosphate | BLOOD MONONUCLEAR-CELLS | DNA-POLYMERASES | PERFORMANCE LIQUID-CHROMATOGRAPHY | LC-MS/MS | SUBSTRATE-SPECIFICITY | DEOXYCYTIDINE KINASE | HUMAN RIBONUCLEOTIDE REDUCTASE | CHRONIC LYMPHOCYTIC-LEUKEMIA | Adenine Nucleotides - analysis | Neoplasms - metabolism | Chromatography, High Pressure Liquid - methods | Humans | Cladribine - analogs & derivatives | Antineoplastic Agents - metabolism | Adenosine Triphosphate - metabolism | Arabinonucleosides - analysis | Vidarabine - metabolism | Tandem Mass Spectrometry - methods | Arabinonucleosides - metabolism | Limit of Detection | Polyphosphates - analysis | Adenosine Triphosphate - analysis | Cladribine - analysis | Antineoplastic Agents - analysis | Vidarabine - analogs & derivatives | Vidarabine - analysis | Adenosine Triphosphate - analogs & derivatives | Polyphosphates - metabolism | Neoplasms - drug therapy | Cladribine - metabolism | Adenine Nucleotides - metabolism | Spectrometry, Mass, Electrospray Ionization - methods | Cell Line, Tumor | Antimitotic agents | Metabolites | Ionization | Cancer cells | Nitriles | Lymphomas | Liquid chromatography | Antineoplastic agents | Mass spectrometry | Cancer | Nucleosides | Life Sciences
Journal Article